• 2009

Company Description

Valevia developer antibacterial medications.

The company was founded in 2009 as Valevia in Switzerland to develop antibacterial medications. AVX13616 (now VAL301) was licensed from the Australian drug development company Avexa . Subsequently, the company headquarters were moved to the UK in 2012 and was renamed Valevia UK. Valevia’s lead project is supported by a TSB feasibility grant, which was awarded in 2013.